The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF) Una manera de hacer Europa [SAF2014/57708R, SAF2015/31242R]
2. Redes Tematicas de Investigacion Cooperativa de Cancer from the Instituto de Salud Carlos III (ISCIII) [RD12/0036/0004, RD12/0036/0023, RD12/0036/0038]
3. Instituto de Salud Carlos III (ISCIII) [PIE1313/00033]
4. PP-G
5. Generalitat de Catalunya [AGAUR 2014-SRG-967]